Prelone and Localised osteoarthritis - a phase IV clinical study of FDA data


Localised osteoarthritis is reported only by a few people who take Prelone.

The phase IV clinical study analyzes which people take Prelone and have Localised osteoarthritis. It is created by eHealthMe based on reports of 763 people who have side effects while taking Prelone from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On May, 14, 2022

763 people reported to have side effects when taking Prelone.
Among them, 5 people (0.66%) have Localised osteoarthritis.

What is Prelone?

Prelone has active ingredients of prednisolone. It is often used in asthma. eHealthMe is studying from 826 Prelone users for its effectiveness, alternative drugs and more.

What is Localised osteoarthritis?

Localised osteoarthritis (infection of joint affects only single joint) is found to be associated with 361 drugs and 103 conditions by eHealthMe.

Number of Prelone and Localised osteoarthritis reports submitted per year:

Could Prelone cause Localised osteoarthritis?

Gender of people who have Localised osteoarthritis when taking Prelone *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Localised osteoarthritis when taking Prelone *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Prelone *:

  1. Yasmin: 5 people, 100.00%
  2. Vioxx: 5 people, 100.00%
  3. Sandimmune: 5 people, 100.00%
  4. Lexapro: 3 people, 60.00%

Common side effects people have besides Localised osteoarthritis *:

  1. Intracranial Venous Sinus Thrombosis (presence of thrombosis (a blood clot) in the dural venous sinuses, which drain blood from the brain): 5 people, 100.00%
  2. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 100.00%
  3. Joint Effusion (presence of extra fluid in joint covering): 5 people, 100.00%
  4. Visual Disturbance: 5 people, 100.00%
  5. Insomnia (sleeplessness): 5 people, 100.00%
  6. Indigestion: 5 people, 100.00%
  7. Hypochromic Anaemia (hypochromic anaemia is a generic term for any type of anaemia in which the red blood cells (erythrocytes) are paler than normal): 5 people, 100.00%
  8. Hot Flush (sudden feelings of heat): 5 people, 100.00%
  9. Heart Rate Irregular: 5 people, 100.00%
  10. Headache (pain in head): 5 people, 100.00%

Common conditions people have *:

  1. Menstruation Irregular: 5 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Prelone and have Localised osteoarthritis?

Check whether Localised osteoarthritis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of Prelone:

Localised osteoarthritis treatments and more:

COVID vaccines that are related to Localised osteoarthritis:

How severe was Localised osteoarthritis and when was it recovered:

Expand to all the drugs that have ingredients of prednisolone:

Common drugs associated with Localised osteoarthritis:

All the drugs that are associated with Localised osteoarthritis:

All the conditions that are associated with Localised osteoarthritis:

How the study uses the data?

The study uses data from the FDA. It is based on prednisolone (the active ingredients of Prelone) and Prelone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: